Definity and Idiopathic diffuse interstitial pulmonary fibrosis - a phase IV clinical study of FDA data

Summary:

Idiopathic diffuse interstitial pulmonary fibrosis is reported only by a few people who take Definity.

The phase IV clinical study analyzes which people take Definity and have Idiopathic diffuse interstitial pulmonary fibrosis. It is created by eHealthMe based on reports of 3,835 people who have side effects while taking Definity from the FDA, and is updated regularly.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.



On Aug, 06, 2022

3,835 people reported to have side effects when taking Definity.
Among them, 2 people (0.05%) have Idiopathic diffuse interstitial pulmonary fibrosis.


What is Definity?

Definity has active ingredients of perflutren. eHealthMe is studying from 3,851 Definity users for its effectiveness, alternative drugs and more.

What is Idiopathic diffuse interstitial pulmonary fibrosis?

Idiopathic diffuse interstitial pulmonary fibrosis (interstitial lung disease) is found to be associated with 2,414 drugs and 2,047 conditions by eHealthMe.

Number of Definity and Idiopathic diffuse interstitial pulmonary fibrosis reports submitted per year:

Could Definity cause Idiopathic diffuse interstitial pulmonary fibrosis?

Time on Definity when people have Idiopathic diffuse interstitial pulmonary fibrosis *:

  • < 1 month: 100 %
  • 1 - 6 months: 0.0 %
  • 6 - 12 months: 0.0 %
  • 1 - 2 years: 0.0 %
  • 2 - 5 years: 0.0 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

Gender of people who have Idiopathic diffuse interstitial pulmonary fibrosis when taking Definity *:

  • female: 100 %
  • male: 0.0 %

Age of people who have Idiopathic diffuse interstitial pulmonary fibrosis when taking Definity *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 0.0 %
  • 50-59: 0.0 %
  • 60+: 100 %

Common drugs people take besides Definity *:

  1. Zosyn: 2 people, 100.00%
  2. Lopressor: 2 people, 100.00%
  3. Cipro: 2 people, 100.00%
  4. Combivent Respimat: 2 people, 100.00%
  5. Decadron: 2 people, 100.00%
  6. Deltasone: 2 people, 100.00%
  7. Diflucan: 2 people, 100.00%
  8. Diprivan: 2 people, 100.00%
  9. Flagyl: 2 people, 100.00%
  10. Flexeril: 2 people, 100.00%

Common side effects people have besides Idiopathic diffuse interstitial pulmonary fibrosis *:

  1. Thrombocytopenia (decrease of platelets in blood): 2 people, 100.00%
  2. Septic Shock (shock due to blood infection): 2 people, 100.00%
  3. Gastric Ulcer Perforation (stomach hole due to ulcer): 2 people, 100.00%
  4. Abdominal Sepsis (abdominal infection): 2 people, 100.00%

Common conditions people have *:

  1. Joint Pain: 2 people, 100.00%
  2. Indigestion: 2 people, 100.00%
  3. Breathing Difficulty: 2 people, 100.00%
  4. Constipation: 2 people, 100.00%
  5. Cough: 2 people, 100.00%
  6. Deep Venous Thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis): 2 people, 100.00%
  7. Diarrhea: 2 people, 100.00%
  8. Gastrointestinal Perforation (hole in the digestive tract): 2 people, 100.00%
  9. Headache (pain in head): 2 people, 100.00%
  10. High Blood Pressure: 2 people, 100.00%

* Approximation only. Some reports may have incomplete information.

Do you take Definity and have Idiopathic diffuse interstitial pulmonary fibrosis?

Check whether Idiopathic diffuse interstitial pulmonary fibrosis is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related studies

How severe was Idiopathic diffuse interstitial pulmonary fibrosis and when was it recovered:

Expand to all the drugs that have ingredients of perflutren:

Alternative drugs to, pros and cons of Definity:

Common Definity side effects:

Browse all side effects of Definity:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Idiopathic diffuse interstitial pulmonary fibrosis treatments and more:

COVID vaccines that are related to Idiopathic diffuse interstitial pulmonary fibrosis:

Common drugs associated with Idiopathic diffuse interstitial pulmonary fibrosis:

All the drugs that are associated with Idiopathic diffuse interstitial pulmonary fibrosis:

Common conditions associated with Idiopathic diffuse interstitial pulmonary fibrosis:

All the conditions that are associated with Idiopathic diffuse interstitial pulmonary fibrosis:

How the study uses the data?

The study uses data from the FDA. It is based on perflutren (the active ingredients of Definity) and Definity (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: